Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-17-372414
Filing Date
2017-12-19
Accepted
2017-12-18 19:41:47
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM S-3/A d489256ds3a.htm S-3/A 309430
2 EX-4.2 d489256dex42.htm EX-4.2 22122
3 EX-5.1 d489256dex51.htm EX-5.1 17801
4 EX-12.1 d489256dex121.htm EX-12.1 26313
5 EX-23.1 d489256dex231.htm EX-23.1 1804
6 EX-23.2 d489256dex232.htm EX-23.2 5280
7 GRAPHIC g489256g84s99.jpg GRAPHIC 6071
  Complete submission text file 0001193125-17-372414.txt   392098
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: S-3/A | Act: 33 | File No.: 333-221402 | Film No.: 171262574
SIC: 2834 Pharmaceutical Preparations